ABSTRACT: Application of AI in extensive beef cattle production would be facilitated by protocols that effectively synchronize ovarian follicular development and ovulation to enable fixed-time AI (TAI). The objectives were to determine whether use of a controlled internal drug release (CIDR) device to administer progesterone in a GnRH-based estrous synchronization protocol would optimize blood progesterone concentrations, improve synchronization of follicular development and estrus, and increase pregnancy rates to TAI in beef cows. Beef cows (n = 1,240) in 6 locations within the US Meat Animal Research Center received 1 of 2 treatments: 1) an injection of GnRH [100 µg intramuscularly (i.m.)] followed by PGF 2α (PGF; 25 mg i.m.) 7 d later (CO-Synch), or 2) CO-Synch plus a CIDR during the 7 d between GnRH and PGF injections (CO-Synch + CIDR). Cows received TAI and GnRH (100 µg i.m.) at 60 h after PGF. Progesterone was measured by RIA in blood samples collected 2 wk before and at initiation of treatment (d 0) and at PGF injection (d 7). Estrous behavior was monitored by Estrotect Heat Detectors. Pregnancy was diagnosed by ultrasonography 72 to 77 d after TAI. Plasma progesterone concentrations did not differ (P > 0.10) between synchronization protocols at first GnRH injection (d 0), but progesterone was greater (P < 0.01) at PGF injection (d 7) in cows receiving CO-Synch + CIDR vs. CO-Synch as a result of fewer CIDR-treated cows having progesterone ≤1 ng/ mL at PGF (10.7 vs. 29.6%, respectively). A greater (P < 0.01) proportion of CO-Synch + CIDR vs. COSynch cows were detected in estrus within 60 h after PGF (66.7 vs. 57.8 ± 2.6%, respectively) and a greater (P < 0.01) proportion were pregnant to TAI (54.6 vs. 44.3 ± 2.6%, respectively). For both synchronization protocols, cows expressing estrus within 60 h before TAI had a greater pregnancy rate than cows without estrus. For cows with plasma progesterone ≤1 ng/mL at PGF injection, CO-Synch + CIDR increased pregnancy rate (65.2 ± 5.9 vs. 30.8 ± 3.4% with vs. without CIDR), whereas pregnancy rates did not differ (P > 0.10) between protocols (52.1 ± 2.1 vs. 50.0 ± 2.4%, respectively) when progesterone was >1 ng/mL (treatment × progesterone; P < 0.01). Inclusion of a CIDR in the synchronization protocol increased plasma progesterone concentration, proportion of cows detected in estrus, and pregnancy rate; however, the increase in pregnancy rate from inclusion of the CIDR was primarily in cows with decreasing or low endogenous progesterone secretion during treatment.
INTRODUCTION
Secretion of progesterone by the bovine corpus luteum (CL) plays a major role in regulating the estrous cycle and maintaining the uterus to support fetal development. Greater blood progesterone concentrations during the estrous cycle preceding breeding may increase conception (Cushman et al., 2007) . In other studies, progesterone concentrations were greater 3 to 8 d after breeding in cows becoming pregnant compared with nonpregnant cows, implying that increased progesterone facilitated conception or embryo development (Inskeep, 2004) . Methods to regulate ovulation in farm animals by changing or supplementing endogenous progesterone release have been investigated extensively for more than 50 yr (Hansel, 1961) , but the fertility of regulated estrous cycles is still variable.
The progesterone-impregnated controlled internal drug release (CIDR) device in combination with GnRH and PGF 2α (PGF) may provide a more effective method (CO-Synch + CIDR; Lamb et al., 2001) for synchronizing estrus and ovulation in beef cattle than PGF alone or with GnRH (CO-Synch), especially in anestrous postpartum cows and prepubertal heifers . A preliminary assessment of the CO-Synch + CIDR treatment revealed that 80% of the treated cows were detected in estrus between 36 and 84 h after CIDR removal, and pregnancy rates ranged between 60 and 70% when bred by AI 12 h after onset of estrus. Improved synchronization of ovulation to enable fixed-time AI (TAI) would facilitate use of AI in large beef cattle herds by eliminating the need for twice-daily monitoring of estrus and requiring less sorting of cattle. Experimental objectives were to determine the efficacy of TAI in beef cows treated with CO-Synch, with or without the CIDR for 7 d, in an extensive beef cattle management system and to determine the influence of changes in blood progesterone concentrations and expression of estrus on fertility to TAI.
MATERIALS AND METHODS
The experimental design and procedures used in this study were approved by the US Meat Animal Research Center (USMARC) Animal Care and Use Committee.
Animals and Experimental Design
Cross-bred, postpartum beef cows were administered 1 of 2 TAI estrous synchronization protocols during the fall (November) 2007 (n = 661 cows) and spring (June) 2008 (n = 579 cows) breeding seasons. Cows ranged from 3 to 10 yr of age and from 26 to 91 d postpartum; 104 cows were transferred from the previous breeding season and were >120 d postpartum. Within each breeding season, cows were distributed by genetic type among 3 locations and adjoining animal handling facilities within the USMARC. A BCS was determined and recorded for each cow at the initiation of treatment (d 0) using a scoring schedule of 1 to 9 (NRC, 1996) . Animals were provided ad libitum grass pasture pre-and postbreeding.
Synchronization Treatment Protocols. Within location and breeding season, cows were assigned equally by breed type, age, lactation status, BCS, and postpartum interval (days from calving to treatment) to either of 2 treatment protocols: 1) CO-Synch or 2) CO-Synch + CIDR . The CO-Synch treatment consisted of an injection of GnRH [100 µg intramuscularly (i.m.); OvaCyst, IVX Animal Health Inc., St. Joseph, MO] at the initiation of the treatment (d 0), followed by an injection of PGF (25 mg i.m.; Lutalyse, Pfizer Animal Health, New York, NY) 7 d later (d 7). One-half of the CO-Synch-treated cows within a location were assigned by genotype and phenotype to receive a CIDR (1.38 mg of progesterone; Pfizer Animal Health) intravaginally on d 0, which was removed 7 d later (CO-Synch + CIDR). All cows were TAI at 60 h (range 59 to 62 h) after PGF regardless of estrus and received an injection of GnRH (100 µg i.m.) at AI. Each AI technician randomly inseminated an equal number of cows in both treatment groups at multiple locations. Technician identity and sire information were recorded for each TAI mating. Sires used in the experiment were selected to achieve preplanned matings. Ten days after the TAI, cows were housed in multiple breeding pastures with 2 fertile bulls per pasture for a 22-d natural breeding period.
Reproductive Status. Ovarian cyclicity (cyclic vs. anestrus) was determined by measurement of blood progesterone and by monitoring estrous behavior using Estrotect Heat Detectors (Rockway Inc., Spring Valley, WI). A blood sample (9 mL) was collected from the tail by venipuncture into heparinized syringes (15 IU of lithium-heparin, Sarstedt Inc., Newton, NC) at 2 wk before treatment and at d 0 and 7 of the synchronization protocol; samples were stored on ice until processing. Plasma was recovered from blood by centrifugation (1,250 × g for 20 min at 4°C) and stored at −20°C until assayed for progesterone by RIA. A plasma progesterone concentration >1 ng/mL in the initial blood sample or on d 0 was interpreted to reflect the presence of a functional CL. Progesterone concentrations on d 7 were used to assess the relationship between progesterone priming and conception. The Estrotect Heat Detector patch was installed on the tail head of each cow 2 wk before treatment. Status of the detectors was recorded at d 0 and 7 of treatment, coinciding with blood collections, and at TAI; activated detectors were replaced at each reading.
In addition to the 10 d between TAI and natural service, conception to TAI vs. subsequent natural service was further confirmed based on fetal size and stage of anatomical development measured transrectally by real-time ultrasonography 72 to 77 d after TAI using a 3.5-MHz convex-array probe (Aloka 500, Corometrics Medical Systems, Wallingford, CT; Echternkamp and Gregory, 1999) and by calving date. Pregnancy rate to TAI was calculated as the proportion of cows within a treatment group conceiving to TAI divided by the total number of cows within the treatment group. Proportion of cows detected in estrus within 60 h before TAI was calculated accordingly.
Progesterone Analysis. Progesterone concentrations were quantified directly in plasma for the 3 blood samples collected from each cow using a commercial solid-phase RIA kit (Coat-A-Count, Siemens Medical Diagnostics Solutions, Los Angeles, CA). The intraassay CV was 2.6%, and the interassay CV was 2.9%. Minimal detectable amount of progesterone in plasma was 0.05 ng/mL.
Statistical Analyses
Treatment effects on proportion of cows pregnant to TAI, proportion of cows detected in estrus during the 60 h before TAI, or overall pregnancy rate were tested by PROC GLIMMIX procedure (SAS Inst. Inc., Cary, NC) for binomial data. Independent fixed effects included in the statistical model were treatment, season, location, ovarian cyclicity (anestrus vs. cyclic), postpartum interval group (days from calving to d 0 grouped as ≤40 d, by 10-d intervals from 41 to 90 d, and >90 d), AI technician, BCS, and their 2-way interactions; cow age was included as a covariate. The effects of cyclicity, BCS, and AI technician were not significant (P > 0.10) and, along with the nonsignificant (P > 0.10) interactions, were removed from the final model. To analyze the effects of treatment and plasma progesterone concentrations (d 0, d 7, or the difference between d 0 and 7) on pregnancy rate to TAI or estrus detection, progesterone concentrations were categorized by 1-ng/mL increments from 0 to 5 ng/mL, at 2-ng/mL increments from 5.1 to 9 ng/mL, and then >9 ng/mL on d 0 or 7, or as ≤1 or >1 ng/mL on d 7. Categorical groupings by change in progesterone between d 0 and 7 (d 7 − d 0) were −17 to −8 ng/mL, 2 ng/mL from −8 to 0 ng, 1 ng/mL from 0 to 5 ng, 2 ng/mL from 5 to 7 ng, and >7 ng/mL; increment sizes were varied to obtain uniform distribution of animal numbers among categories. Data for progesterone effects on fertility were analyzed by PROC GLIMMIX; independent fixed effects included in the model were treatment, plasma progesterone category (d 0, d 7, or the difference between d 0 and 7), season, location, and their 2-way interactions; cow age was included as a covariate. In addition, linear and quadratic relationships between progesterone concentrations on d 0 or 7 and estrus detection or pregnancy rate were tested by regression analysis in PROC GLIM-MIX with progesterone concentration, treatment, and location in the model as independent variables. Factors affecting plasma progesterone concentrations on d 0 or 7 were determined by PROC GLM (SAS Inst. Inc.). Independent variables included in the model were treatment, season, location, and postpartum interval; cow age was included as a covariate. Effects of season, location, and cow age on ovarian cyclicity and the interval from parturition to initiation of the treatments also were determined by PROC GLM. Relationships among plasma progesterone concentrations on d 0 or 7 and reproductive traits were assessed by PROC CORR (SAS Inst. Inc.).
RESULTS

Treatment
Reproductive Status. Sixty-six cows (5.3%) had a plasma progesterone concentration ≤1 ng/mL in blood samples collected 2 wk before and on d 0 of initiation of the synchronization protocols plus an inactivated patch on d 0. These cows were categorized as acyclic and included 24 cows in fall 2007 (12 CO-Synch and 12 COSynch + CIDR) compared with 42 cows in spring 2008 (22 CO-Synch and 20 CO-Synch + CIDR). Proportion of cyclic cows was not affected (P > 0.10) by season, cow age, or location, but the interval from parturition to initiation of the treatments (d 0) was shorter (P < 0.01) for acyclic cows than for cyclic cows (56.2 ± 1.6 vs. 70.4 ± 0.2 d, respectively). In addition, the interval from parturition to initiation of the treatments was shorter (P < 0.01) in fall 2007 than in spring 2008 (55.9 ± 0.2 vs. 70.7 ± 0.2 d, respectively).
Pregnancy Rate. Pregnancy rate to TAI, as well as the proportion of cows detected in estrus before TAI, was greater (P < 0.01) for cows receiving the CO-Synch + CIDR vs. CO-Synch protocol (Table 1 ). In addition, pregnancy rates to TAI were greater (P < 0.01) for cows detected in estrus vs. those not detected in estrus within 60 h before TAI (56.4 ± 2.6 vs. 37.4 ± 2.3%, respectively) in both treatments and seasons. The treatment × season interaction was not significant (P > 0.10) for either pregnancy rate or estrus. Pregnancy rate to TAI (Table 1 ), but not proportion of cows in estrus, was less (P < 0.05) for cows ≤40 d postpartum compared with cows 51 to 60 d, 61 to 70 d, or 81 to 90 d postpartum at the initiation of treatments. Conversely, pregnancy rate did not differ (P > 0.10) between cows that were cyclic (n = 1174) vs. acyclic (n = 66) at initiation of treatment (48.9 ± 1.8 vs. 39.5 ± 6.4%, respectively), among the 3 breeding locations, among BCS (range = 4 to 8), or by their interactions, but the proportion of cows detected in estrus before TAI differed among the 3 locations and among locations by season (location × season; P < 0.01). Pregnancy rate to TAI decreased (P < 0.05) with increasing cow age (range = 3 to 10 yr) and tended (P = 0.09) to be less in spring 2008 vs. fall 2007 (Table 1) .
Pregnancy rate for the total breeding season (i.e., TAI + 22 d of natural service) did not differ (P > 0.10) between the CO-Synch vs. CO-Synch + CIDR protocols (88.7 vs. 87.7 ± 1.3%, respectively), between fall 2007 vs. spring 2008 seasons (86.6 vs. 89.8 ± 13.0%, respectively), among the 3 breeding locations, or their interactions. Among cows diagnosed pregnant to TAI, 95.8% calved and their calving rate was not influenced (P > 0.10) by synchronization treatment, season, or breeding location and was similar (P > 0.10) to the calving rate (95.9%) for TAI + 22 d of natural service combined.
Plasma Progesterone Concentrations. Plasma progesterone concentrations (Table 1) at initiation of the synchronization protocols (d 0) did not differ (P > 0.10) among cows assigned to the CO-Synch + CIDR vs. CO-Synch synchronization protocols, whereas the mean was approximately 1 ng/mL greater (P < 0.01) at the end of the treatment period (d 7) in cows treated with CO-Synch + CIDR vs. CO-Synch. Magnitude of the progesterone difference on d 7 between synchronization protocols was less in fall 2007 (3.7 vs. 3.2 ± 0.1 ng/mL) than in spring 2008 (5.4 vs. 4.1 ± 0.1 ng/mL), respectively (treatment × season; P < 0.05).
On d 0 of treatment, plasma progesterone concentrations were greater (P < 0.05) in fall 2007 than spring 2008 (4.0 vs. 3.5 ± 0.1 ng/mL, respectively), whereas on d 7, concentrations were less (P < 0.01) in cows treated in fall 2007 than in spring 2008 (3.3 vs. 4 .6 ± 0.1 ng/mL, respectively). Progesterone concentrations (Table 1) on both d 0 and 7 of treatment increased (P < 0.01) with duration of interval from parturition to initiation of treatment and differed among the 3 locations within and between seasons (location × season; P < 0.01 and P < 0.05, respectively). Plasma progesterone concentrations were not affected (P > 0.10) by cow age or BCS on either day; however, progesterone concentrations were correlated negatively (P < 0.01) on d 0 with cow age and BW and on d 7 with BW (Table 2) .
Relationship Between Plasma Progesterone Concentrations and Pregnancy to TAI
Collectively, prebreeding plasma progesterone concentrations did not differ (P > 0.10) between cows conceiving or not conceiving to TAI when evaluated for either d 0 (3.9 vs. 3.8 ± 0.1 ng/mL, respectively) or d 7 (4.0 vs. 4.1 ± 0.1 ng/mL, respectively) of treatment. Cows were subsequently categorized by absolute plasma progesterone concentrations on either d 0 (Table 3) or d 7 (Table 4 ) of treatment or their difference (Table 5) . The relationship between pregnancy rate to TAI and progesterone concentrations on d 0 was not affected by treatment (P > 0.10), whereas plasma progesterone concentrations on d 7 contributed to fertility differences between treatments (progesterone category × treatment; P < 0.01) as did the change in progesterone concentration between the 2 treatment days. Pregnancy rates (Table 4) were less (P < 0.01) for CO-Synch- Table 1 . Effects of synchronization treatment, season, location, and postpartum interval on plasma progesterone (P4) concentrations, proportion of cows detected in estrus, and pregnancy rate to fixed-time AI 2 CIDR = controlled internal drug release device. Number of observations was n = 1,240. Positive or negative coefficients ≥0.08 are significant at P < 0.01. Coefficients of 0.07 are significant at P < 0.05. treated cows having plasma progesterone concentrations ≤1 ng/mL on d 7 of treatment compared with CO-Synch cows having concentrations of 1.1 to 9.0 ng/ mL or compared with CO-Synch + CIDR-treated cows having progesterone concentrations ≤4.0, 5.1 to 7.0, or >9.0 ng/mL on d 7. The decreased pregnancy rate for CO-Synch cows with progesterone ≤1 ng/mL on d 7 (29.6% of cows) contributed significantly to the difference in pregnancy rate between the 2 synchronization protocols. Within the CO-Synch + CIDR treatment, pregnancy rate to TAI was greater (P < 0.05) for cows with progesterone concentrations ≤4 ng/mL on d 7 of treatment compared with those having concentrations of 4.1 to 5.0 or 7.1 to 9.0 ng/mL on d 7. In addition, the regression analysis revealed a linear (P < 0.01) negative relationship between progesterone concentration on d 7 and pregnancy rate that differed (P < 0.01) between treatments because of a decreased pregnancy rate in CO-Synch-treated cows with progesterone concentrations ≤1 ng/mL on d 7.
The comparison of plasma progesterone concentrations between d 0 and 7 of treatment revealed that progesterone increased in 61.1% of the CO-Synch + CIDR cows and in 56.6% of the CO-Synch cows during the 7-d period. When fertility was assessed by categorical changes in progesterone concentration between d 0 and 7 (Table 5) , pregnancy rate decreased linearly (P < 0.05) with an increase in plasma progesterone concen- Means within a column without a common superscript differ (P < 0.05).
1
Proportion of treated females detected in estrus before TAI at 60 h after PGF 2α and proportion pregnant to TAI. Plasma progesterone categorized by concentration on d 0 of treatment (GnRH injection) at 1-ng/mL increments from 0 to 5 and at 2-ng/mL increments from 5.1 to 9 ng/mL. Means within a trait without a common superscript differ (P < 0.05).
Proportion of treated females detected in estrus before TAI and proportion pregnant to TAI at 60 h after PGF 2α .
2 CIDR = controlled internal drug release device. Plasma progesterone categorized by concentration on d 7 of treatment (PGF injection) at 1-ng/mL increments from 0 to 5 ng/mL and at 2-ng/ mL increments from 5.1 to 9 ng/mL, or as being ≤1 or >1 ng/mL. trations on d 7 relative to d 0 within the CO-Synch + CIDR treatment, whereas the effect of changing progesterone concentration on fertility was inconsistent within the CO-Synch treatment (progesterone × treatment; P < 0.05). Specifically, pregnancy rate to TAI was greater (P < 0.05) among CO-Synch + CIDR cows in which differences in plasma progesterone concentrations between d 7 and 0 were −2.1 to −16.6 ng/mL compared with those in which progesterone increased >5.0 ng/ mL between d 0 and 7 of treatment. The reduced fertility for CO-Synch + CIDR-treated cows in which progesterone increased >5.0 ng/mL between d 0 and 7 is consistent with the decrease in pregnancy rate to TAI associated with increasing progesterone concentrations on d 7 of treatment. In contrast, pregnancy rates were reduced (P < 0.05) in CO-Synch-treated cows in which plasma progesterone concentrations decreased >4 ng/ mL between d 0 and 7 compared with CO-Synch + CIDR-treated cows with a reduction in progesterone >4 ng/mL. Among CO-Synch cows, pregnancy rates were greater (P < 0.05) when progesterone decreased from −2.01 to −4.0 ng/mL compared with increasing 4.1 to 8.0 ng/mL or decreasing >4 ng/mL.
Relationship Between Plasma Progesterone Concentrations and Estrus
Proportion of cows detected in estrus within 60 h before TAI was affected (P < 0.01) by plasma progesterone concentrations on both d 0 (Table 3 ) and d 7 (Table 4) of treatment, but the relationship differed between the 2 sampling times. Estrus-detection rate (Table 2 ) was greatest (P < 0.01) for cows with progesterone concentrations >9 ng/mL on d 0 of treatment, whereas fewer cows were detected in estrus (P < 0.05) when plasma progesterone on d 0 ranged from 2.1 to 3.0 or 3.1 to 4.0 ng/mL compared with the other progesterone groups. In contrast, estrus detection was inversely related (r = −0.38; P < 0.01) to plasma progesterone concentrations on d 7 of treatment (Table  4) , decreasing (P < 0.01) with increasing progesterone concentrations in a linear (P < 0.01) negative relationship that differed (P < 0.01) between treatments. Among cows having plasma progesterone ≤3.0 ng/mL on d 7 (Table 4), the incidence of estrus was greater for cows receiving the CO-Synch + CIDR vs. CO-Synch treatment, whereas the incidence did not differ between treatments among cows with progesterone >3.0 ng/mL (progesterone category × treatment; P < 0.01).
Collectively, plasma progesterone concentrations were greater (P < 0.01) on d 7 for cows not detected vs. detected in estrus before TAI (5.6 vs. 2.9 ± 0.1 ng/ mL, respectively); furthermore, the increased progesterone concentrations on d 7 for cows not detected in estrus were greater (P < 0.01) in CO-Synch + CIDR (6.8 vs. 3.1 ± 0.1 ng/mL, respectively) vs. CO-Synch cows (4.5 vs. 2.7 ± 0.1 ng/mL, respectively; treatment × estrus; P < 0.01). Consequently, the mean for plasma progesterone concentration decreased (−1.4 ± 0.2 ng/ mL) between d 0 and 7 of treatment in cows detected in estrus vs. an increase of 2.0 ± 0.2 ng/mL between d 0 and 7 in cows not detected in estrus (P < 0.01). The decrease in progesterone for cows detected in estrus was similar for CO-Synch + CIDR-treated (−1.2 ± 0.2 ng/ mL) and CO-Synch-treated (−1.5 ± 0.3 ng/mL) cows (P > 0.10), whereas the increase in progesterone for Means within a trait without a common superscript differ (P < 0.05). 1 Proportion of treated females detected in estrus before TAI at 60 h after PGF 2α and proportion pregnant to TAI.
2 Change in plasma progesterone concentrations during treatment (d 7 minus d 0). Plasma progesterone concentrations decreased in 38.8% and increased in 61.1% of the CO-Synch-treated females during treatment compared with 43.0 and 57.1%, respectively, for the CO-Synch + controlled internal drug release (CIDR)-treated females.
cows not detected in estrus was greater (P < 0.01) for CO-Synch + CIDR-treated (3.3 ± 0.3 ng/mL) vs. COSynch-treated (0.7 ± 0.3 ng/mL) cows.
DISCUSSION
The synchronization protocols employed in this study were designed to regulate ovarian follicular development and ovulation by increasing progesterone inhibition of these physiological events by either increasing endogenous progesterone secretion with an injection of GnRH or GnRH plus administration of exogenous progesterone for 7 d (CIDR). Inclusion of the CIDR treatment in the CO-Synch synchronization protocol increased pregnancy rate to TAI 10.3 percentage units as reported previously (Lamb et al., 2001 (Lamb et al., , 2010 Larson et al., 2006) . This difference in fertility between the 2 protocols was primarily linked to differences in pregnancy rate among cows with plasma progesterone concentrations ≤1 ng/mL at PGF injection on d 7 of treatment. For cows with progesterone ≤1 ng/mL, pregnancy rate was 34 percentage units less for the COSynch protocol compared with the CO-Synch + CIDR protocol, whereas fertility did not differ between protocols for cows having plasma progesterone >1 ng/mL on d 7. Concurrent with the decreased fertility, a smaller percentage of the CO-Synch-vs. CO-Synch + CIDRtreated cows having plasma progesterone ≤1 ng/mL on d 7 was detected in estrus within 60 h before TAI.
The initial 100-µg GnRH injection does not stimulate LH release and induce ovulation and accessory CL or extend CL function in all beef cattle (Geary et al., 2000; Perry and Perry, 2009 ). Failure to extend luteal function results in a reduction in blood progesterone concentrations and its negative progesterone feedback on LH release during treatment (Echternkamp et al., 1976; Kinder et al., 1996) , permitting premature ovulation or formation of persistent follicles with a poorquality oocyte (Ahmad et al., 1995; Perry et al., 2007) . Such scenarios likely account for the greater proportion of CO-Synch-treated cows with progesterone ≤1 ng/ mL on d 7 and reduced fertility to TAI, whereas progesterone release from the CIDR was sufficient to block estrus, ovulation, and formation of persistent dominant follicles during treatment, thus increasing pregnancy rate to TAI in CO-Synch + CIDR-treated cows with progesterone ≤1 ng/mL on d 7.
Within the CO-Synch + CIDR protocol, both pregnancy rate and proportion of cows detected in estrus were greater among cows with plasma progesterone concentrations ≤4 and ≤3 ng/mL, respectively, at PGF injection (d 7). Furthermore, regression analysis revealed that pregnancy rate and expression of estrus decreased linearly with increasing plasma progesterone concentrations on d 7 alone or relative to d 0 in both treatment protocols, but the slope differed between treatments.
Presumably, cows with negative d 7 minus d 0 concentrations had a functional CL at the initiation of treatment that underwent luteolysis during the treatment period, but CO-Synch + CIDR-treated cows had either sufficient endogenous progesterone or progesterone released from the CIDR, or both, to block ovulation until after removal of the CIDR. After CIDR removal and PGF injection, development and ovulation of the ovulatory follicle likely occurred more synchronously in relation to time of AI among CO-Synch + CIDRtreated cows with decreased progesterone, resulting in an increased conception rate. In contrast, a premature decrease in progesterone in CO-Synch-treated cows advances development of the ovulatory follicle and estrus in relation to TAI, including some incidences of estrus occurring before the injection of PGF on d 7 (Geary et al., 2000) . Conversely, cows in which the initial GnRH injection induced accessory ovulations may have possessed new developing CL or accessory CL that were less sensitive to PGF on d 7, or the additional luteal mass required additional time for completion of luteolysis. The delayed luteolysis and increased blood progesterone concentrations would delay follicle recruitment and ovulation and alter their relationship to time of AI, resulting in decreased conception to TAI. Length of proestrus and its relationship to growth and development of the dominant follicle at TAI can affect both conception and CL development during the subsequent estrous cycle (Perry et al., 2007; Bridges et al., 2010) . Bridges et al. (2010) hypothesized that the increased pregnancy rate for the 5-d CO-Synch + CIDR with TAI at 72 h after PGF resulted from the longer proestrus, allowing development of a young dominant follicle. The decreased fertility for the CO-Synch + CIDR-treated cows with plasma progesterone >1 ng/mL on d 7 may imply reason to administer PGF 12 to 24 h before removal of the CIDR, or use of additional treatments to enhance CL regression and reduce progesterone more quickly. Plasma progesterone concentrations on d 0 of treatment, or 10 d in advance of TAI, did not influence fertility directly for either synchronization protocol, but cows with greater progesterone concentrations on d 0 than on d 7 had increased pregnancy rates.
A greater percentage of the CO-Synch + CIDR than CO-Synch cows was detected in estrus within the first 60 h after PGF, but this difference between treatments in estrus expression occurred only among cows with progesterone concentrations ≤3.0 ng/mL on d 7 of treatment. Generally, cows having small systemic concentrations of progesterone at CIDR removal come into estrus sooner (Stevenson et al., 2000) , which concurred with the general trend for the percentage of cows detected in estrus to decrease as plasma progesterone concentration on d 7 increased, and for more cows with reduced progesterone on d 7 to express estrus within 60 h after termination of the treatments. Regardless of treatment, cows detected in estrus before or at TAI had a greater pregnancy rate than those not detected in estrus, which concurs with previous findings that cows exhibiting standing estrus within 24 h before TAI had increased estradiol concentrations and pregnancy rates compared with cows not exhibiting estrus (Perry et al., 2007) . Increased estrogen concentrations around estrus may influence fertility through more efficient transportation of sperm through the female reproductive tract (Hawk, 1983) and increased fertilization efficiency by altering the uterine environment and decreasing uterine pH to increase the viable lifespan of sperm (Jones and Bavister, 2000) . In contrast, pregnancy rate being greater than estrous detection in CO-Synch + CIDR-treated cows with progesterone >5 ng/mL on d 7, infers that fertile ovulations were advanced by the GnRH injection at TAI in some cows with increased progesterone.
Performing TAI in both synchronization protocols at 60 h rather than at 66, 54, or 48 h after PGF on d 7 was based on results from a comparison of estrus synchronization between cows treated with the Select Synch vs. Select Synch + CIDR protocol ; the distribution of estrus after PGF was very similar between the 2 protocols, including 80% of the cows being detected in estrus between 36 and 72 h after PGF in both protocols. In addition, a preliminary study at USMARC revealed that 81.3% of CO-Synch + CIDRtreated cows were in estrus between 36 and 84 h after PGF on d 7 (unpublished data). Furthermore, when these CO-Synch + CIDR-treated cows were bred by AI 12 h after onset of estrus, pregnancy rate (60 to 70%) was not affected by the time interval from PGF to onset of estrus, indicating that fertility to TAI is influenced by the interval of time between AI and ovulation rather than the length of time at which estrus occurs after PGF. In contrast, other investigators reported that induction of ovulation in small developing preovulatory follicles (<11 mm diameter) reduced associated pregnancy rates in both synchronized cattle (Perry et al., 2007) and twin-ovulating cattle (Echternkamp et al., 2009) , indicating that maturation of the preovulatory follicle and oocyte is required for optimal fertility. Experiments comparing fertility for TAI at 66 vs. 54 h after PGF showed either 5 percentage units increase in pregnancy rates for TAI at 66 h (Busch et al., 2008) or no difference between times (Dobbins et al., 2009; Wilson et al., 2010) . Because timing of ovulation relative to CL regression is variable and influenced by several factors, achieving optimal timing of TAI with ovulation is challenging and unpredictable, thus accounting for the variation in results among herds and locations.
In addition to regulating estrus and ovulation in cattle, progesterone facilitates maternal recognition of pregnancy and prepares the uterus for implantation and development of the conceptus. Some studies have shown that administration of exogenous progesterone (e.g., CIDR) within the synchronization protocol enhanced estrus and pregnancy rate in prepubertal heifers and anestrous postpartum cows . In the present study, only 5.3% of the cows were categorized as acyclic before initiation of the synchronization protocols, and pregnancy rate did not differ between synchronization protocols for this small proportion of acyclic or early postpartum cows.
Cows in the present study were >35 d postpartum on d 0, had a BCS ranging between 5 and 8, and were provided ad libitum access to improved pasture, all factors that likely contributed to the greater incidence of cyclicity. Conversely, pregnancy rates and plasma progesterone concentrations on d 0 were reduced within both synchronization protocols for cows ≤40 d vs. >50 d postpartum, and it is speculated that the decreased progesterone concentration on d 0 of treatment contributed to their reduced pregnancy rate.
On d 7 of treatment, 10.7% of the CO-Synch + CIDRtreated cows had blood progesterone concentrations ≤1 ng/mL at CIDR removal. Such small concentrations were not anticipated because previous assessments of in vivo progesterone release from the CIDR in nonlactating, ovariectomized Holstein cows (Rathbone et al., 2002) found the mean for progesterone in blood on d 7 of CIDR treatment to be approximately 3 ng/mL. Both studies used the same commercial progesterone RIA, and cows were of similar BW. In contrast, administration of a progesterone-releasing intravaginal device containing 1.9 mg of progesterone yielded blood progesterone concentrations ranging from 1 to 2.7 mg/mL on d 8 of treatment in ovariectomized Holstein cows (Stevenson and Mee, 1991) , which is consistent with current results. Furthermore, blood progesterone concentrations did not differ between cows receiving a CIDR containing 1.3 vs. 1.9 g of progesterone (Rathbone et al., 2002) . Because blood progesterone concentrations are influenced by diet, feed intake, and metabolic status (Sangsritavong et al., 2002) , differences in progesterone concentrations among studies may reflect animal differences in progesterone metabolism.
In conclusion, the proportion of cows detected in estrus and pregnant to TAI at 60 h after PGF was increased for cows receiving the CO-Synch + CIDR synchronization protocol, but the primary difference in fertility between synchronization protocols occurred in cows with plasma progesterone concentrations ≤1 ng/ mL on d 7 of treatment. It is speculated that progesterone from the CIDR was sufficient to extend proestrus and improve synchronization of follicular development and ovulation in relation to time of AI, whereas ovulation occurred prematurely in relation to TAI within the CO-Synch-treated cows with low blood progesterone concentrations on d 7, compromising fertility. Thus, inclusion of treatments to lengthen proestrus and delay ovulation in CO-Synch-treated females without a functional CL may increase pregnancy rate. Conversely, inclusion of treatments to facilitate regression of the CL at CIDR removal (e.g., administering PGF 12 or 24 h before removal of the CIDR) in cows with enhanced CL function may further improve synchronization of ovulation and fertility in CO-Synch + CIDR-treated cows. Collectively, use of TAI with either the CO-Synch or CO-Synch + CIDR synchronization protocol yielded acceptable pregnancy rates in a typical large, extensive, cow-calf beef production system, and the 2 synchronization protocols had no adverse effects on subsequent fertility to natural service. Although pregnancy was not diagnosed until 72 to 77 d after TAI, fetal survival or overall maintenance of pregnancy did not appear to differ between synchronization protocols.
